RAB3GAP2

Chr 1AR

RAB3 GTPase activating non-catalytic protein subunit 2

Also known as: MARTS1, RAB3-GAP150, RAB3GAP150, SPG69, WARBM2, p150

The protein encoded by this gene belongs to the RAB3 protein family, members of which are involved in regulated exocytosis of neurotransmitters and hormones. This protein forms the Rab3 GTPase-activating complex with RAB3GAP1, where it constitutes the regulatory subunit, whereas the latter functions as the catalytic subunit. This gene has the highest level of expression in the brain, consistent with it having a key role in neurodevelopment. Mutations in this gene are associated with Martsolf syndrome.[provided by RefSeq, Oct 2009]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.292 OMIM phenotypes
Clinical SummaryRAB3GAP2
🧬
Gene-Disease Validity (ClinGen)
Warburg micro syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.99). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
50 unique Pathogenic / Likely Pathogenic· 395 VUS of 883 total submissions
📖
GeneReview available — RAB3GAP2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.29LOEUF
pLI 0.987
Z-score 6.85
OE 0.19 (0.130.29)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
0.87Z-score
OE missense 0.91 (0.850.97)
645 obs / 710.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.19 (0.130.29)
00.351.4
Missense OE?0.91 (0.850.97)
00.61.4
Synonymous OE?0.92
01.21.6
LoF obs/exp: 16 / 83.6Missense obs/exp: 645 / 710.1Syn Z: 1.05
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveRAB3GAP2-related Martsolf syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.3196th %ile
GOF
0.3094th %ile
LOF
0.75top 10%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

883 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic28
VUS395
Likely Benign298
Benign67
Conflicting34
22
Pathogenic
28
Likely Pathogenic
395
VUS
298
Likely Benign
67
Benign
34
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
18
3
1
0
22
Likely Pathogenic
22
5
1
0
28
VUS
5
332
50
8
395
Likely Benign
0
9
149
140
298
Benign
0
4
61
2
67
Conflicting
34
Total45353262150844

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

31 pathogenic / likely-pathogenic (of 42) ClinVar copy-number / structural variants overlap RAB3GAP2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

RAB3GAP2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →